| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4de0228d3a80c6034035033d0f86a435 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815c5411f643836cc65aa383a203cf3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_930caf75ee7ea91510daaf8fa3a8d712 |
| publicationDate |
2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020000061-A1 |
| titleOfInvention |
Renal treatment |
| abstract |
The invention relates to a method for minimizing a symptom of glomerulonephritis in an individual having a kidney or renal disease, comprising the administration of a TR47 related peptide to the individual. The TR47 related peptide generally refers to a peptide that has a N-terminal sequence NH 2 -NPND or NH 2 -NPNDKY, which is derived from the N-terminal residues of Met 1 -Arg 46 deleted human PAR1 (protease activated receptor 1) sequence. |
| priorityDate |
2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |